Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -117.69% is 72% above its 4-year average of -422.85%, near the high end of its 4-year range (-849.46%–-101.09%).
As of the fiscal period ended Tuesday, June 30, 2026. 71.12% above its 12-month average of -407.57%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -117.69%.
RETURN ON EQUITY (ROE)
-117.69%
RETURN ON EQUITY (ROE) AVG TTM
-407.57%
RETURN ON EQUITY (ROE) AVG 3Y
-500.43%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+71.12%
CURRENT VS 3Y AVG
+76.48%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-180.14%
vs the sector median at left
Quantum Cyber N.V.
Market Cap
$29.37M
Return on Equity (ROE)
-117.69%
TTM Avg
-407.57%
3Y Avg
-500.43%
5Y Avg
N/A
Market Cap
$29.57M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$29.74M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
Market Cap
$29.91M
Return on Equity (ROE)
-116.14%
TTM Avg
-228.74%
3Y Avg
113.10%
5Y Avg
76.03%
Market Cap
$30.19M
Return on Equity (ROE)
-14.49%
TTM Avg
-7.92%
3Y Avg
-46.98%
5Y Avg
-261.20%
Market Cap
$28.47M
Return on Equity (ROE)
N/A
TTM Avg
29.33%
3Y Avg
173.42%
5Y Avg
64.03%
Market Cap
$28.31M
Return on Equity (ROE)
N/A
TTM Avg
78.98%
3Y Avg
134.04%
5Y Avg
114.40%
Market Cap
$30.44M
Return on Equity (ROE)
-15.29%
TTM Avg
-28.05%
3Y Avg
-476.74%
5Y Avg
-371.52%
Market Cap
$28.10M
Return on Equity (ROE)
-83.26%
TTM Avg
-46.97%
3Y Avg
-39.40%
5Y Avg
-27.49%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $29.37M | -117.69% | -407.57% | -500.43% | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | -120.40% | -43.89% | -83.08% | -65.54% |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | -111.81% | -29.10% | -257.52% | 159.26% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | -116.14% | -228.74% | 113.10% | 76.03% |
| Rockwell Medical, Inc. (RMTI)vs › | $30.19M | -14.49% | -7.92% | -46.98% | -261.20% |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A | 29.33% | 173.42% | 64.03% |
| OneMedNet Corporation (ONMD)vs › | $28.31M | N/A | 78.98% | 134.04% | 114.40% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.44M | -15.29% | -28.05% | -476.74% | -371.52% |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | -83.26% | -46.97% | -39.40% | -27.49% |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | -65.05% | -525.23% | -779.21% | -536.29% |
ROE
-117.7%
ROA
-102.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -117.69% |
| 2026-03-31 | -354.95% |
| 2025-06-30 | -750.06% |
| 2025-03-31 | -351.62% |
| 2024-12-31 | -360.11% |
| 2024-09-30 | -358.37% |
| 2023-12-31 | -809.29% |
| 2023-09-30 | -849.46% |
| 2023-06-30 | -552.35% |
| 2023-03-31 | -281.94% |
| 2022-12-31 | -187.20% |
| 2022-06-30 | -101.09% |
